An article in The Economist highlights how a number of researchers at MIT are developing new devices to regulate the delivery of drugs within the body. Prof Michael Cima is working on a drug-delivery technology that could be used to treat ovarian cancer.
Researchers at MIT and Harvard have developed a new device that can quickly detect Ebola, reports Robert Preidt for U.S. News & World Report. “The new paper-based test takes minutes and the device does not require electricity,” writes Preidt. “The test works in a similar manner to over-the-counter pregnancy tests.”
A team led by Prof. Michael Cima is developing an implantable sensor that can monitor a tumor’s response to cancer drugs, writes Eric Levenson for Boston.com. “The sensor would function like a long-term medical biopsy, giving doctors a continuous look at how a tumor is developing,” Levenson explains.
Jamie Ducharme writes for Boston Magazine that MIT researchers are developing a biochemical sensor that could provide updates on cancerous tumors. The sensor “could be implanted in cancerous tissue during a patient’s first biopsy. After that, it would stay in the tissue and transmit data about the state of the tumor to an external device.”
Jamie Ducharme of Boston Magazine writes about a polymer gel being developed by researchers from MIT and Massachusetts General Hospital that could allow for swallowable medical devices. “Improving slow-release safety could open the door for devices that control hunger in obese patients, diagnose gastrointestinal issues, extend the effects of drugs, and more,” Ducharme explains.
MIT researchers have “developed a new ring-like device made of a polymer that can deliver drugs to the stomach over the course of a week,” writes Alexandra Ossola for Popular Science. The team anticipates that the technology could be used for a variety of medical applications.
A new study on cancer drug development by MIT researchers found that pharmaceutical firms overlook drugs for early-stage tumors, writes Jordan Graham for The Boston Herald. “There’s dramatically more investments in the late-stage treatments,” says Prof. Benjamin Roin.
MIT researchers have found that nitrous oxide or laughing gas is a stronger anesthetic than previously believed, writes Nitya Rajan for The Huffington Post. The researchers found that nitrous oxide caused changes in patient brainwaves and a pattern of electrical firing across the brain.
Miles O’Brien of the PBS NewsHour reports on how scientists are developing cheaper and more efficient tests for Ebola, highlighting Prof. Lee Gehrke’s simple diagnostic kits. Gehrke explains that the test his team developed is “very simple, requires no refrigeration, no power, no special training.”
“MIT researchers have created an algorithm [that] can distinguish between different lymphomas in real time,” writes Melissa Malamut for Boston Magazine. Graduate student Yuan Luo and Professor Peter Szolovits developed a system that can automatically suggest cancer diagnoses based on data points from past pathology reports, Malamut explains.
Mark Shanahan writes for The Boston Globe that the organizers of HUBweek, an innovation-themed festival designed to showcase Boston’s leadership in education, medicine, technology and the arts, gathered at a launch party last week. As part of HUBweek, MIT will host “Solve,” an event designed to bring together leaders in a variety of areas to tackle global challenges.
In a piece for The Huffington Post, Zeynep Ilyaz explains how Prof. Sangeeta Bhatia serves as an inspiration to her, citing her research advances in biotech and medicine, and her mentorship of women pursuing careers in STEM fields. “Dr. Bhatia is constantly looking for the next groundbreaking discovery in health, which makes her an excellent role model for girls and women,” Ilyaz writes.
Prof. Nikhil Agarwal has found that a lack of positions at prestigious institutions leads to low salaries among medical residents, reports Angela Chen for The Wall Street Journal. Agarwal found that, "applicants are willing to pay an 'implicit tuition'...to have a prestigious and high-demand residency."
MIT researchers have developed a test for Ebola and other fevers using gold nanoparticle sensors that quickly identify the pathegon, writes Andrea Timpano for Boston Magazine. “It is important to recognize that the United States needs to have strategies for surveillance that will identify dangerous viruses,” says Professor Lee Gehrke.
“A promising new diagnostic test from MIT looks like it could be a game changer for rapidly diagnosing several important infectious diseases within minutes,” writes Judy Stone for Forbes. The paper test developed by MIT researchers can diagnose Ebola, yellow fever and dengue fever.